Joel Edward Kleinman

Joel Edward Kleinman's AcademicInfluence.com Rankings

Philosophy

#6202

World Rank

#9200

Historical Rank

Logic

#3390

World Rank

#4539

Historical Rank

philosophy Degrees

Joel Edward Kleinman

Biology

#8400

World Rank

#11469

Historical Rank

Neuroscience

#1160

World Rank

#1202

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Joel Edward Kleinman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joel Edward Kleinman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Spatiotemporal transcriptome of the human brain (2011) (1683)
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. (2004) (1637)
Temporal dynamics and genetic control of transcription in the human prefrontal cortex (2011) (645)
Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. (2016) (523)
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia (2003) (516)
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. (1995) (469)
Integrative functional genomic analysis of human brain development and neuropsychiatric risks (2018) (464)
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. (2004) (402)
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function (2003) (371)
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. (2004) (365)
Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex (2015) (361)
Candidate Endophenotypes for Genetic Studies of Suicidal Behavior (2009) (356)
Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics (1993) (354)
DNA methylation signatures in development and aging of the human prefrontal cortex. (2012) (353)
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. (1993) (335)
Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. (2006) (323)
Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain (2003) (322)
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia (1993) (309)
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. (2007) (309)
Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment. (1980) (305)
Genetic variation in CACNA1C affects brain circuitries related to mental illness. (2010) (295)
Large-Scale Cellular-Resolution Gene Profiling in Human Neocortex Reveals Species-Specific Molecular Signatures (2012) (284)
Expression of GABA Signaling Molecules KCC2, NKCC1, and GAD1 in Cortical Development and Schizophrenia (2011) (282)
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia (2004) (279)
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study (2002) (275)
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression (2007) (272)
Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia (2006) (249)
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. (1993) (239)
Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis (2018) (235)
Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex (2020) (232)
Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. (2014) (231)
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. (2007) (223)
BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. (2006) (208)
A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation (2013) (203)
Course of schizophrenia: neuropsychological evidence for a static encephalopathy. (1993) (198)
Cerebellar pathology in schizophrenia: a controlled postmortem study. (1980) (195)
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia (2002) (191)
Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. (2007) (188)
Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia (2005) (188)
The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. (1990) (187)
DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms (2009) (185)
BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. (2002) (179)
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia (2005) (176)
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. (2006) (175)
A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. (1989) (171)
Sex differences in glutamate receptor gene expression in major depression and suicide (2015) (171)
Intravenous naloxone administration in schizophrenia and affective illness. (1977) (169)
Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness (2004) (162)
Molecular and cellular reorganization of neural circuits in the human lineage (2017) (162)
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain (2004) (161)
Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia (2008) (155)
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. (1997) (153)
Is There Cognitive Decline in Schizophrenia? (1994) (152)
Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia (2003) (150)
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. (2004) (149)
Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia (1991) (149)
Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study. (2016) (147)
Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. (1991) (145)
Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9. (2003) (145)
APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms (2014) (143)
Age-related differences in glucocorticoid receptor mRNA levels in the human brain (2007) (143)
Dopamine receptor subtype imbalance in schizophrenia. (1987) (142)
Neuropathology of bipolar disorder (2000) (141)
Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients (2008) (141)
Dynamic regulation of RNA editing in human brain development and disease (2016) (140)
Developmental regulation of human cortex transcription and its clinical relevance at base resolution (2014) (138)
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone (2000) (136)
Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat (1990) (132)
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia (1999) (131)
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy (2012) (130)
Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation (2003) (130)
Speaking, thinking, and blinking (1981) (129)
A novel, primate-specific, brain isoform of KCNH2 impacts cortical physiology, cognition, neuronal repolarization and risk for schizophrenia (2009) (129)
A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus (2016) (129)
Decreased density of human striatal dopamine uptake sites with age. (1986) (123)
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development (2003) (123)
Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. (1986) (123)
Ex uno multi: subtyping the schizophrenic syndrome. (1982) (122)
Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain (2010) (122)
Spontaneous asymmetric circling behavior in hemi-parkinsonism; a human equivalent of the lesioned-circling rodent behavior. (1987) (107)
Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia (2008) (106)
Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. (1983) (103)
Choline acetyltransferase in schizophrenia. (1993) (103)
A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. (1997) (102)
Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706. (2014) (100)
Myelin, myelin-related disorders, and psychosis (2015) (99)
Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia (1999) (97)
Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains (1997) (96)
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder (2014) (94)
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia (2013) (94)
Epigenetic mechanisms in schizophrenia. (2009) (94)
Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients (2004) (93)
Alteration in Estrogen Receptor α mRNA Levels in Frontal Cortex and Hippocampus of Patients with Major Mental Illness (2005) (93)
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia (2010) (91)
Smaller frontal gray matter volume in postmortem schizophrenic brains. (2002) (91)
Gene Expression of Metabolic Enzymes and a Protease Inhibitor in the Prefrontal Cortex Are Decreased in Schizophrenia (2004) (88)
Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease (2006) (88)
[3H]GBR‐12935 Binding to the Dopamine Transporter Is Decreased in the Caudate Nucleus in Parkinson's Disease (1987) (88)
Psychiatric Brain Banking: Three Perspectives on Current Trends and Future Directions (2011) (87)
Transcript-Specific Associations of SLC12A5 (KCC2) in Human Prefrontal Cortex with Development, Schizophrenia, and Affective Disorders (2012) (87)
Genetic Neuropathology of Schizophrenia: New Approaches to an Old Question and New Uses for Postmortem Human Brains (2011) (86)
Neuropathology of schizophrenia (1982) (86)
Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain (2014) (85)
Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder (2017) (84)
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs (2018) (84)
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic‐induced dyskinesias (1994) (84)
Prenatal expression patterns of genes associated with neuropsychiatric disorders. (2014) (82)
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse (2003) (81)
Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. (1996) (80)
BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders (2015) (79)
Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain (2018) (78)
Reduced haloperidol in the post-mortem brains of haloperidol-treated patients (1984) (78)
Reliability of psychiatric diagnosis in postmortem research (2005) (77)
Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1 (2016) (77)
Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals (1998) (77)
Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain (2018) (76)
Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients (1994) (75)
Abnormal Expression of Cell Recognition Molecules in Schizophrenia (1998) (75)
qSVA framework for RNA quality correction in differential expression analysis (2017) (74)
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. (1997) (73)
Altered expression of histamine signaling genes in autism spectrum disorder (2017) (73)
A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis (2001) (71)
Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. (2007) (70)
A comparison of verbal fluency tasks in schizophrenic patients and normal controls (2001) (69)
Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects (1997) (69)
Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression (2014) (68)
Distribution of beta‐adrenergic receptor subtypes in human post‐mortem brain: Alterations in limbic regions of schizophrenics (1992) (68)
Plasma prolactin concentrations and psychopathology in chronic schizophrenia. (1982) (68)
Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP (2008) (65)
Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia (2001) (65)
Drug Metabolism in Human Brain: High Levels of Cytochrome P4503A43 in Brain and Metabolism of Anti-Anxiety Drug Alprazolam to Its Active Metabolite (2008) (65)
Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds (2008) (64)
Reduced Density of Cholinergic Interneurons in the Ventral Striatum in Schizophrenia: An In Situ Hybridization Study (2005) (63)
Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. (2016) (63)
Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex (2013) (63)
The neuropathology of schizophrenia. (1988) (61)
Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects (2002) (60)
Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. (2001) (60)
Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex (2005) (59)
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay (2004) (58)
Transcriptional Changes Common to Human Cocaine, Cannabis and Phencyclidine Abuse (2006) (58)
Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain (1993) (57)
Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia. (2013) (56)
Wheat gluten challenge in schizophrenic patients. (1981) (56)
Properties of [3H]AMPA Binding in Postmortem Human Brain from Psychotic Subjects and Controls: Increases in Caudate Nucleus Associated with Suicide (1993) (56)
D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment (1992) (56)
Evidence of Sex-Modulated Association of ZNF804A with Schizophrenia (2011) (55)
Characteristics of the Cation Cotransporter NKCC1 in Human Brain: Alternate Transcripts, Expression in Development, and Potential Relationships to Brain Function and Schizophrenia (2014) (54)
A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls (1996) (53)
RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. (2006) (53)
GABA concentrations in forebrain areas of suicide victims (1988) (53)
Investigating the neuroimmunogenic architecture of schizophrenia (2018) (53)
Divergent neuronal DNA methylation patterns across human cortical development reveal critical periods and a unique role of CpH methylation (2018) (52)
Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats (1999) (52)
Drug effect on blink rates in rhesus monkeys: preliminary studies. (1981) (50)
Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients (1987) (50)
Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease (2018) (50)
Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients. (1980) (50)
A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue (2017) (49)
VASE-Containing N-CAM Isoforms Are Increased in the Hippocampus in Bipolar Disorder but Not Schizophrenia (1998) (49)
Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk (2020) (49)
A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia (1993) (49)
Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences (1992) (49)
Molecular landscapes of human hippocampal immature neurons across lifespan (2022) (48)
CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders. (2015) (48)
Human Obesity Associated with an Intronic SNP in the Brain-Derived Neurotrophic Factor Locus. (2015) (48)
GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia (2018) (48)
The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia. (1991) (48)
Neuroleptics decrease blinking in schizophrenic subjects. (1981) (48)
Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype (2011) (47)
Neurons with Complex Karyotypes Are Rare in Aged Human Neocortex. (2019) (47)
Astrocytosis in the molecular layer of the dentate gyrus: A study in Alzheimer's disease and schizophrenia (1990) (47)
Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. (1994) (46)
Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex (2008) (45)
Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia (2004) (45)
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (2012) (44)
The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain. (2010) (42)
Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. (1996) (42)
The Schizophrenia Syndrome: Examples of Biological Tools for Subclassification (1981) (42)
Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment. (2013) (41)
Neurexin 1 (NRXN1) Splice Isoform Expression During Human Neocortical Development and Aging (2015) (41)
Seasonal variation in human central dopamine activity (1984) (41)
Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals. (2014) (40)
A 5′ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression (2009) (39)
Synaptophysin protein and mRNA expression in the human hippocampal formation from birth to old age (2006) (39)
A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain. (2005) (38)
Basic fibroblast growth factor and fibroblast growth factor receptor-1 in the human hippocampal formation (2005) (38)
Single-nucleus transcriptome analysis reveals cell-type-specific molecular signatures across reward circuitry in the human brain (2021) (37)
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements (1994) (37)
Metabotropic Glutamate Receptor 2 and 3 Gene Expression in The Human Prefrontal Cortex and Mesencephalon in Schizophrenia (2008) (37)
Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases. (1980) (37)
Haloperidol-Induced Changes in Blink Rates Correlate with Changes in BPRS Score (1982) (37)
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (2018) (36)
Axonal counts of the corpus callosum of schizophrenic patients. (1989) (36)
Quantitative magnetic resonance imaging in Rett syndrome. (1991) (36)
Analysis of Copy Number Variations in Brain DNA from Patients with Schizophrenia and Other Psychiatric Disorders (2012) (36)
Dopamine and its metabolites in human peripheral nerves: is there a widely distributed system of peripheral dopaminergic nerves? (1981) (35)
Muscarinic binding in suicides (1984) (35)
USING CNS TISSUE IN PSYCHIATRIC RESEARCH: A Practical Guide (1999) (35)
The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system (2005) (35)
Age-related changes in [3H]GBR 12935 binding site density in the prefrontal cortex of controls and schizophrenics (1995) (35)
3H-paroxetine binding in brains of alcoholics (1991) (34)
Discordant changes in cortical TrkC mRNA and protein during the human lifespan (2005) (33)
CATECHOLAMINES AND METABOLITES IN THE BRAINS OF PSYCHOTICS AND NORMALS: POST-MORTEM STUDIES (1979) (32)
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia (2020) (32)
Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders. (2017) (32)
Eye-blinking and cerebral ventricular size in chronic schizophrenic patients. (1984) (31)
Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain (2016) (30)
Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia (2006) (30)
The neuroanatomy and neurochemistry of schizophrenia. (1998) (30)
Neuropeptides in human brain—postmortem studies (1985) (29)
Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19) (2019) (29)
DLPFC transcriptome defines two molecular subtypes of schizophrenia (2017) (29)
Characteristics of [3H]GBR 12935 Binding in the Human and Rat Frontal Cortex (1991) (29)
Practical impacts of genomic data “cleaning” on biological discovery using surrogate variable analysis (2015) (29)
Use of Postmortem Human Dura Mater and Scalp for Deriving Human Fibroblast Cultures (2012) (29)
Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients. (1991) (28)
Quantitative shape analysis of the temporal and prefrontal lobes of schizophrenic patients: a magnetic resonance image study. (1990) (28)
Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton (2006) (28)
Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age (2015) (28)
Glutamate receptor changes in brain synaptic membranes from human alcoholics (1990) (28)
POSTMORTEM NEUROCHEMICAL STUDIES IN CHRONIC SCHIZOPHRENIA (1982) (27)
A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. (1979) (27)
High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex (2017) (27)
Central catecholamines, cognitive impairment, and affective state in elderly schizophrenics and controls (1987) (26)
The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia. (2003) (26)
Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity (2009) (26)
Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia (2018) (26)
Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients (1979) (26)
alpha-Adrenergic receptor function in schizophrenia. (1980) (26)
Sex differences in glutamate receptor gene expression in major depression and suicide (2015) (25)
An Inverse Correlation between Spontaneous Eye-Blink Rate and Platelet Monoamine Oxidase Activity (1983) (25)
Increased expression of MARCKS in post-mortem brain of violent suicide completers is related to transcription of a long, noncoding, antisense RNA (2014) (25)
Crow's 'lateralization hypothesis' for schizophrenia. (1991) (25)
Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects (2005) (24)
The neuropathology of schizophrenia: A critical assessment of research methodologies (1990) (24)
Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala (1993) (24)
Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development. (2014) (24)
Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia (2019) (23)
A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. (2006) (23)
Cerebellar and frontal cortical benzodiazepine receptors in human alcoholics and chronically alcohol-drinking rats (1992) (23)
Genetic Variation in FGF20 Modulates Hippocampal Biology (2010) (23)
Apomorphine response and subtyping of schizophrenia (1983) (23)
Improved selective ion monitoring mass-spectrometric assay for the determination of N,N-dimethyltryptamine in human blood utilizing capillary column gas chromatography. (1979) (23)
AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls (2001) (23)
Staining intensity of brain iron in patients with schizophrenia: a postmortem study. (1992) (23)
Dementia Praecox Revisited (1988) (22)
No Effect of a Common Allelic Variant in the Reelin Gene on Intermediate Phenotype Measures of Brain Structure, Brain Function, and Gene Expression (2010) (22)
A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. (1977) (22)
Evaluation of tissue collection for postmortem studies of bipolar disorder. (2008) (22)
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls. (1985) (22)
The subnuclear distribution of 5-HT3 receptors in the human nucleus of the solitary tract and other structures of the caudal medulla (1994) (21)
Expression of the myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP) in the prefrontal cortex and hippocampus of suicide victims. (1999) (21)
Characterizing the nuclear and cytoplasmic transcriptomes in developing and mature human cortex uncovers new insight into psychiatric disease gene regulation (2019) (21)
Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia (1991) (20)
Single-nucleus transcriptome analysis reveals cell type-specific molecular signatures across reward circuitry in the human brain (2020) (20)
DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain (2015) (20)
Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition. (2020) (20)
Genome-wide sequencing-based identification of methylation quantitative trait loci and their role in schizophrenia risk (2021) (20)
Genetic risk mechanisms of posttraumatic stress disorder in the human brain (2016) (20)
Search for Cytomegalovirus in Schizophrenic Brain Tissue (1981) (20)
Blink rates and receptor supersensitivity (1981) (19)
A postmortem quantitative study of iron in the globus pallidus of schizophrenic patients (1990) (19)
Erratum to: Practical impacts of genomic data “cleaning” on biological discovery using surrogate variable analysis (2015) (19)
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders (2002) (19)
NURR1 and ERR1 Modulate the Expression of Genes of a DRD2 Coexpression Network Enriched for Schizophrenia Risk (2019) (19)
Strong Components of Epigenetic Memory in Cultured Human Fibroblasts Related to Site of Origin and Donor Age (2015) (19)
GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders (2016) (19)
Changes in NMDA Receptor Subunit mRNAs and Cyclophilin mRNA during Development of the Human Hippocampus (2003) (18)
Diurnal variation in tardive dyskinesia (1995) (18)
Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes. (2004) (18)
Naloxone in chronic schizophrenic patients: Neuroendocrine and behavioral effects (1982) (18)
Monoclonal antibodies to study the brain in schizophrenia (1989) (18)
Erratum: Sex differences in glutamate receptor gene expression in major depression and suicide (Molecular Psychiatry (2015) 20 (1139)) doi:10.1038/mp.2015.114 (2015) (18)
Characterizing the dynamic and functional DNA methylation landscape in the developing human cortex (2019) (17)
P-chlorophenylalanine trials in schizophrenic patients. (1982) (17)
Interactions of human truncated DISC1 proteins: implications for schizophrenia (2011) (16)
Postmortem measurements of neuropeptides in human brain (1983) (16)
Neuropathology of Suicide (1997) (16)
Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose (2005) (16)
Neuropathological findings in a suspected case of childhood schizophrenia. (1990) (15)
Expression of DISC 1 binding partners is reduced in schizophrenia and associated with DISC 1 SNPs (2006) (15)
Differential diagnosis of choreiform tardive dyskinesia. (1991) (15)
Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia. Failure to observe consistent or specific behavioral and neuropathological effects. (1988) (15)
Characterization of [125I]SCH 23982 binding in human brain: Comparison with [3H]SCH 23390 (1991) (15)
CLINICAL STUDY: Postmortem diagnosis and toxicological validation of illicit substance use (2008) (14)
Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study (2016) (14)
Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex (2008) (14)
Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia. (1980) (13)
Human locus coeruleus neurons express the GABAA receptor γ2 subunit gene and produce benzodiazepine binding (2010) (13)
Association of a Noncoding RNA Postmortem With Suicide by Violent Means and In Vivo With Aggressive Phenotypes (2019) (13)
Erratum: The hippocampus and parahippocampus in schizophrenia, suicide, and control brains (Archives of General Psychiatry (1990) 47 (1029)) (1991) (13)
Coupling efficiency of brain β-adrenergic receptors to Gs protein in suicide, alcoholism and control subjects (1999) (12)
Postmortem neurochemistry in schizophrenia. (1986) (12)
Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance. (2016) (12)
Alterations in TRH receptors in temporal lobe of schizophrenics: A quantitative autoradiographic study (1994) (12)
Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia (1981) (11)
Genetic and epigenetic analysis of schizophrenia in blood—a no-brainer? (2016) (11)
Muscarinic Receptor Density in Skin Fibroblasts and Autopsied Brain Tissue in Affective Disorder a (1986) (11)
Developmental effects of maternal smoking during pregnancy on the human frontal cortex transcriptome (2017) (11)
Implementation and clinical characteristics of a posttraumatic stress disorder brain collection (2018) (11)
Decoding shared versus divergent transcriptomic signatures across cortico-amygdala circuitry in PTSD and depressive disorders (2021) (11)
Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokers (2019) (11)
Postmortem study of the dopaminergic d1 receptors in the dorsolateral prefrontal cortex of schizophrenics and controls (1990) (11)
THE ASSOCIATION OF LESION‐INDUCED REDUCTIONS IN BRAIN MONOAMINES WITH ALTERATIONS IN STRIATAL CARBOHYDRATE METABOLISM 1 (1973) (10)
52 NEUROCHEMISTRY OF SCHIZOPHRENIA : GLUTAMATERGIC ABNORMALITIES (2002) (10)
Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians (2016) (10)
Amygdala and anterior cingulate transcriptomes from individuals with bipolar disorder reveal down-regulated neuroimmune and synaptic pathways (2022) (10)
Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration. (2015) (10)
Evaluation of superior vermal Purkinje cell placement in mental illness (1999) (10)
Expression of Kinase Interacting with Stathmin (KIS, UHMK1) in human brain and lymphoblasts: effects of schizophrenia and genotype (2009) (10)
Analysis of somatic mutations in 131 human brains reveals aging-associated hypermutability (2022) (10)
PROPRANOLOL TREATMENT OF CHRONIC SCHIZOPHRENIA: CLINICAL RESPONSE, CATECHOLAMINE METABOLISM AND LYMPHOCYTE β-RECEPTORS (1979) (10)
Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients. (1978) (10)
Neuroimaging and neuropathology. (1988) (9)
It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
Genetics and Brain Transcriptomics of Completed Suicide. (2022) (8)
Autoradiographic characterization of 125I-neurotensin binding sites in human entorhinal cortex (1994) (8)
Integrating brain methylome with GWAS for psychiatric risk gene discovery (2018) (8)
Epigenome-wide study of brain DNA methylation following acute opioid intoxication. (2021) (7)
Alterations in Limbic Regions of Schizophrenics (1992) (7)
Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients. (1986) (7)
PCP and sigma receptors in brain are not altered after repeated exposure to PCP in humans. (1991) (7)
A framework for RNA quality correction in differential expression analysis (2016) (7)
105-4 Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides (1997) (6)
TRANSCRIPTOME PROFILING BY RNA SEQUENCING AND EXON MICROARRAY (2013) (6)
Normal nucleolar size of entorhinal cortex cells in Schizophrenia (1992) (6)
Early‐life decline in neurogenesis markers and age‐related changes of TrkB splice variant expression in the human subependymal zone (2017) (6)
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate (1995) (6)
Increased spontaneous eye-blinks cerebellectomized rats. (1981) (6)
INHIBITION OF DOPAMINE SYNTHESIS IN CHRONIC SCHIZOPHRENIA: A FOLLOW-UP STUDY (1979) (6)
Human leukocyte antigen A2 and psychopathology in chronic schizophrenia. (1980) (5)
A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan. (2022) (5)
Genetic and environmental regulation of caudate nucleus transcriptome: insight into schizophrenia risk and the dopamine system (2020) (5)
Assessment of genetic risk for distribution of total interstitial white matter neurons in dorsolateral prefrontal cortex: role in schizophrenia (2016) (5)
Strategies for cellular deconvolution in human brain RNA sequencing data (2020) (5)
Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus (2021) (5)
Relationship between tryptophan and serotonin concentrations in postmortem human brain. (1987) (5)
Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia (2012) (5)
Ventricular enlargement in schizophrenia: is there really a gender effect? (1992) (5)
Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (2018) (4)
Sex differences in the transcription of glutamate transporters in major depression and suicide. (2020) (4)
Computed tomography measurements of brain density in schizophrenia (1991) (4)
Postmortem studies in psychiatry. (1984) (4)
Analysis of the caudate nucleus transcriptome in individuals with schizophrenia highlights effects of antipsychotics and new risk genes (2022) (4)
The Development of a Posttraumatic Stress Disorder Brain Collection (2004) (4)
A postmortem study of the effect of chronic opiate abuse on psychotomimetic binding sites of human frontal cortex (1987) (3)
Expression levels and cellular localization of ErbB receptors mRNAs in the dorsolateral prefrontal cortex in schizophrenia. (2005) (3)
Erratum: DNA methylation signatures in development and aging of the human prefrontal cortex (American Journal of Human Genetics (2012) 90 (260-272)) (2012) (3)
Prefrontal co-expression of schizophrenia risk genes is associated with treatment response in patients (2018) (3)
Reduced dysbindin (DTNBP1) mRNA in hippocampus of patients with schizophrenia (2006) (3)
ABNORMALITIES OF SEROTONERGIC NEURAL TRANSMISSION IN PREFRONTAL CORTEX IN SCHIZOPHRENIA (1992) (3)
Glutamate receptor autoradiography of postmortem basal ganglia in schizophrenia (1994) (3)
Publisher Correction: Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex (2021) (3)
Single molecule in situ hybridization reveals distinct localizations of schizophrenia risk-related transcripts SNX19 and AS3MT in human brain (2021) (3)
96 An immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia: Absence of significant gliosis (1997) (2)
The Subnuclear Distribution of 5-HT1A Receptors in the Human Nucleus of the Solitary Tract and Selected Structures of the Caudal Medulla (2020) (2)
Alterations in bilateral distribution of beta-adrenergic receptor subtypes in schizophrenia and suicide (1989) (2)
Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research (2016) (2)
The gene expression landscape of the human locus coeruleus revealed by single-nucleus and spatially-resolved transcriptomics (2022) (2)
Differential Expression of NPAS4 in the Dorsolateral Prefrontal Cortex Following Acute Opioid Intoxication (2020) (2)
Epigenome-Wide Study of Brain DNA Methylation Among Opioid Users and Controls (2020) (2)
The methylome of the human frontal cortex across development (2014) (2)
Characterization of Na+−Ca2+ exchange activity in plasma membrane vesicles from postmortem human brain (1990) (2)
Integrated single cell and unsupervised spatial transcriptomic analysis defines molecular anatomy of the human dorsolateral prefrontal cortex (2023) (2)
Generation of four postmortem dura-derived iPS cell lines from four control individuals with genotypic and brain-region-specific transcriptomic data available through the BrainSEQ consortium. (2020) (2)
Correction: Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia (2019) (2)
A comparison of human brain dissection by drill versus saw on nucleic acid quality (2009) (2)
Somatic mutations reveal hypermutable brains and are associated with neuropsychiatric disorders (2022) (2)
Comparison of polydipsic behavior in schizophrenia patients on clozapine versus haloperidol (1995) (2)
Alzheimer’s lesions in the brains of young subjects (2015) (2)
Genetic Variation in PCLO Is Associated with Prefrontal Cortex Expression and Bipolar Disorder (2011) (2)
Laterality of appendicular tardive dyskinesia in chronic schizophrenia (1992) (2)
Different profile of the neuroleptic induced upregulation of the dopaminergic d2 receptors in nigrostriatal and mesolimbic systems (1990) (1)
Erratum: Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity (Cell Stem Cell (2014) 15 (79-91)) (2015) (1)
Midbrain tegmental pathology in a case of childhood schizophrenia (1989) (1)
Differential expression of glutamate transporters and monoaminergic genes in major depression and suicide (2019) (1)
Shape and area of hippocampus parahippocampus in schizophrenic suicide and control brains (1988) (1)
Quantitation of astrocytes in the molecular layer of the dentate gyrus in schizophrenic patients (1989) (1)
Pharmacological characterization of the binding of YM09151-2 to D4 dopamine receptor subtypes in basal ganglia and cortex of schizophrenics and controls (1994) (1)
Reduction of GAD-67 MRNA in the striatum of patients with schizophrenia and bipolar disorder (2003) (1)
TECHNICAL WHITE PAPER: IN SITU HYBRIDIZATION (2012) (1)
Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk (2020) (1)
A new approach to the neurobiology of schizophrenia using monoclonal antibodies (1989) (1)
GENDER DIFFERENCES IN SCHIZOPHRENIA. AUTHOR'S REPLIES (1991) (1)
136. Muscarinic receptor protein and mRNA in DLPFC of schizophrenia and affective disorder (2000) (1)
Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides: 13.6 (1995) (1)
In Situ/Histological Approaches to Neurotransmitter-Specific Postmortem Brain Studies of Schizophrenia (2002) (1)
Pathologic Implications for Microtubule-Associated Protein 2 in Schizophrenia Primary Auditory Cortex (2015) (1)
Alterations of neuregulin1 and ErbB4 expression in the cerebellum in schizophrenia (2005) (1)
Does synaptic pathology in schizophrenia involve a selective dendritic spine deficit? A study of spinophilin and MAP2 gene expression in the hippocampus (2003) (1)
Quantitative autoradiography of dopamine D4 receptors in postmortem brains from schizophrenic patients (1994) (1)
Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing (2023) (1)
Single-cell analysis of human trophoblast stem cell specification reveals activation of fetal cytotrophoblast expression programs including coronavirus associated host factors and human endogenous retroviruses (2020) (1)
Studies of Norepinephrine in Schizophrenia (1985) (1)
African-American and Caucasian participation in postmortem human brain donation for neuropsychiatric research (2019) (1)
Suicide in Older Adult Men Is Not Related to a Personal History of Participation in Football (2021) (1)
Abstract 34. Inoculation of schizophrenic brains to rodents and primates: behavioral and neuropathological observations (1985) (1)
Characterization of miRNA Isoform Expression In Schizophrenia Using Postmortem Human Brain Tissue (2019) (0)
Splice variant-specific alterations of neuregulin-1 gene expression in the hippocampus in schizophrenia identified using real-time quantitative RT-PCR. (2004) (0)
Expression of Neuregulin-1, a schizophrenia susceptibility gene, in the normal human brain and in schizophrenia (2004) (0)
Deep learning predicts DNA methylation regulatory variants in the human brain and elucidates the genetics of psychiatric disorders (2022) (0)
Regional heterogeneity in gene expression, regulation and coherence in hippocampus and prefrontal cortex across development and in schizophrenia. Collado-Torres et al, Neuron, 2019. (2019) (0)
Association of a lincRNA postmortem with suicide by violent means and in vivo with aggressive phenotypes (2018) (0)
Abnormalities in neurotensin gene expression levels in the hippocampus of schizophrenics (1998) (0)
Variation in TAF1 Expression in Female Carrier-Induced Pluripotent Stem Cells and Human Brain Ontogeny Has Implications for Adult Neostriatum Vulnerability in X-Linked Dystonia Parkinsonism (2022) (0)
Publisher’s Editorial (1985) (0)
Brain Banking : Three Perspectives on urrent Trends and Future Directions (2010) (0)
Limbic cortical serotonin 1A receptor mRNA in schizophrenia (1995) (0)
Recurrent and Chronic Psychoses (1989) (0)
Exploiting the Variability of CACNA1C Splicing to Identify Novel, Brain-Selective Targets for Schizophrenia and Bipolar Disorder (2020) (0)
Molecular signatures in post mortem brain tissue of individuals at high risk for Alzheimer's disease (2010) (0)
T57IDENTIFYING CAUSAL GENETIC VARIANTS IN PSYCHIATRIC DISORDERS USING SUMMARY DATA BASED MENDELIAN RANDOMIZATION (2019) (0)
SUFI: An automated approach to spectral unmixing of fluorescent biological images (0)
35 OVEREXPRESSION OF MULTIPLE TRANSCRIPTS OF SNX19 (SORTING NEXIN 19) IN MULTIPLE BRAIN REGIONS MAY CONTRIBUTE TO SCHIZOPHRENIA RISK (2019) (0)
90 Postmortem glutamate receptor binding in the prefrontal cortex of schizophrenics and controls (1997) (0)
F180. Temporal Dynamics of miRNAs in Human DLPFC and its Association With miRNA Dysregulation in Schizophrenia (2019) (0)
An Introductory Text for Neuropsychologists. (1987) (0)
CATHECOLAMINES IN THE BRAINS OF SCHIZOPHRENIC PATIENTS (1984) (0)
P509. Tensor-Based Decomposition Associates Striatal Gene Co-Expression With Increased Dopamine Signaling in Individuals at Genetic Risk for Schizophrenia (2022) (0)
Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (2018) (0)
Molecular signature of prodromal Alzheimer's disease: A microarray study in post-mortem cortical tissue (2009) (0)
Tritium labelled paroxetine binding in postmortem brains of schizophrenics suicides cocaine addicts and controls (1990) (0)
GENE CONNECTIVITY ANALYSIS OF CO-EXPRESSION NETWORKS PROVIDES INSIGHTS INTO THE OMNIGENIC MODEL AND IDENTIFIES NOVEL GENETIC HUBS OF SCHIZOPHRENIA RISK (2022) (0)
221 Effect of chronic neuroleptic exposure on mRNA For The AMPA-A subunit of the AMPA glutamate receptor in postmortem human basal ganglia (1997) (0)
Consensus molecular environment of schizophrenia risk genes in coexpression networks shifting across age and brain regions (2023) (0)
ART ICLE Open Ac ce s s DLPFC transcriptome de fi nes two molecular subtypes of schizophrenia (2019) (0)
Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis (2018) (0)
127. Entorhinal cortical preprosomatostatin mRNA in psychiatric disorders (1998) (0)
Gene expression patterns in the DLPFC of patients with schizophrenia and controls (2011) (0)
Postmortem Brain Studies: Focus on Susceptibility Genes in Schizophrenia (2007) (0)
The NRG1/ErbB4 signaling pathway in schizophrenia. From upstream effectors to downstream intracellular signaling networks (2007) (0)
447. Elevated cholecystokinin mRNA in dorsolateral prefrontal cortex in suicides (1996) (0)
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs (2020) (0)
Altered ErbB3 receptor mRNA in the dorsolateral prefrontal cortex in schizophrenia (2005) (0)
Advances in the Neurobiology of Schizophrenia. (1997) (0)
Amphetamine: clinical response of chronic schizophrenics to a single oral dose (1991) (0)
CNV Neurons Are Rare in Aged Human Neocortex (2018) (0)
S-30-5 The neuropathology of schizophrenia: Autoradiographic and in situ hybridization studies (1996) (0)
Genetic and environmental contributions to ancestry differences in gene expression in the human brain (2023) (0)
Comparison of quantitative trait loci methods: Total expression and allelic imbalance method in brain RNA-seq (2019) (0)
Widespread methylation quantitative trait loci and their role in schizophrenia risk (2020) (0)
Postmortem brain collections for neuropsychiatric disorders (2005) (0)
PITUITARY DA-D2 RECEPTORS ARE NOT INCREASED IN TREATED SCHIZOPHRENICS (1994) (0)
148. Altered gene expression of dopaminergic markers in the midbrain of schizophrenic patients (2000) (0)
Spinophilin and MAP2 gene expression in schizophrenia, mood disorder and following neuroleptic treatment in the rat (2003) (0)
262. Human Dg-Seq Reveals Cell-Type-Specific Effectors of Schizophrenia Risk (2018) (0)
Ventral forebrain organoids derived from individuals with schizophrenia recapitulate perturbed striatal gene expression dynamics of the donor’s brains (2022) (0)
Editorial: Biological Psychology/Pharmacopsychology (1985) (0)
Age dependent changes in dopamine transporter binding and its relevance to schizophrenia (1991) (0)
Panel and Study Groups (2013) (0)
Mapping origins of variation in neural trajectories of human pluripotent stem cells (2021) (0)
Analysis of gene expression in Schizophrenia using DNA microarrays (2002) (0)
328. Problems in post-mortem diagnosis can be solved (1996) (0)
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (2018) (0)
Epistasis and Complex Neuropsychiatric Phenotypes (2013) (0)
EVIDENCE OF NEUROGENESIS IN THE SUBEPENDYMAL ZONE OF POSTNATAL HUMAN BRAIN (1999) (0)
vacuous chewing movements in rodents: incidence and effects of long.term increases in haloperidoi dose (1995) (0)
Developmentally-specific interactions between the expression of genes coding for prosocial peptides and dopamine D2 receptor gene expression in the postmortem human brain (2014) (0)
137. Extraction of total RNA in human brain post-mortem tissue: effect of diagnosis on RNA yield (2000) (0)
Pituitary dopamine-D2 receptors are not up-regulated in treated schizophrenic subjects (1993) (0)
Publisher Correction: Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex (2021) (0)
Expression bias in retinoic acid responsive genes defines variations in neural differentiation of human pluripotent stem cells (2022) (0)
Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose (2022) (0)
Contents of The American Journal of Psychiatry (1991) (0)
Genetic and epigenetic analysis of schizophrenia in blood—a no-brainer? (2016) (0)
236. Molecular Dissection of Schizophrenia GWAS Significant Loci (2019) (0)
Neuropsychological specificity and schizophrenia: A comparison with affective groups (1993) (0)
104 An assessment of Purklnje cell placement in the superior cerebellar vermis in mental disease (1997) (0)
Characterization of dopamine uptake sites in the human and rat frontal cortex (1989) (0)
TRIOBP-1 Protein Aggregation Exists in Both Major Depressive Disorder and Schizophrenia, and Can Occur through Two Distinct Regions of the Protein (2022) (0)
Cell Stem CellMing2014Modeling a Genetic Risk for Schizophrenia in iPSCs and Mice Reveals Neural Stem Cell Deficits Associated with Adherens Junctions and Polarity-1 (2014) (0)
505. Striatal preprosomatostatin mRNA in schizophrenia (2000) (0)
Apolipoprotein 2: mRNA expression, protein level, and transcriptomal consequences in human postmortem cortical tissue (2012) (0)
The blink-alpha circuit and gliosis in schizophrenia (1989) (0)
The neuroanatomical basis of psychopathology: The decade of the brain (1994) (0)
Dr. Law and Colleagues Reply (2005) (0)
F104. GENE CO-EXPRESSION NETWORKS REVEAL PATHWAYS OF CONVERGENCE OF SCHIZOPHRENIA RISK GENES AND OF RESPONSE TO TREATMENT (2019) (0)
Editorial: Biological Psychiatry/Pharmacopsychiatry (1985) (0)
Correction: DLPFC transcriptome defines two molecular subtypes of schizophrenia (2019) (0)
Investigating trait variability of gene co-expression network architecture in brain by manipulating genomic signatures of schizophrenia risk (2021) (0)
Influence of Alzheimer’s disease related neuropathology on local microenvironment gene expression in the human inferior temporal cortex (2023) (0)
SUFI: an automated approach to spectral unmixing of fluorescent multiplex images captured in mouse and post-mortem human brain tissues (2021) (0)
ARE COGNITIVE IMPAIRMENTS IN PATIENTS WHO ONLY SUFFER FROM DELUSIONS THE SAME AS SCHIZOPHRENIA PATIENTS? AN EXPLORATORY STUDY (2010) (0)
RNA Sequencing of the Limbic System in Major Depressive Disorder (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Joel Edward Kleinman?

Joel Edward Kleinman is affiliated with the following schools:

Johns Hopkins University

Joel Edward Kleinman's Academic­Influence.com Rankings

Why Is Joel Edward Kleinman Influential?

Joel Edward Kleinman's Published Works

Published Works

What Schools Are Affiliated With Joel Edward Kleinman?

Joel Edward Kleinman's AcademicInfluence.com Rankings